Knowledge Center

In part one, we explore the reasons why the FDA created the (UOU) Unit of Use.

In the third part of the the FDA Unique Device Identification (UDI) “Unit of Use” (UOU) webcast series, we cover several potential use cases for the FDA UDI UOU identifier.

In part two of the FDA Unique Device Identification (UDI) Unit of Use (UOU) webcast series, we cover the FDA definition of the term, Unit of Use.

Millennials will continue to remain significant to the growth of healthcare in years to come. In order to be successful at attracting millennials as patients, a patient-centered approach is required. By Sue MacInnes Download Article

How often have you heard that supply chain is involved in patient care from the moment the patient walks in the door to discharge? Well, now that concept has gone a step further, and we need to think out of the box and as a patient ourselves. Download Article

Download Article

HealthTrust recently created the Physician Advisors Program, which is narrowing the chasm between those who purchase products and those who use them. The program solicits physicians’ input on clinical evidence reviews in product categories that have a significant impact on patient care, specifically physician preference items (PPI). Download Article

Background: In many locations across the country, cold weather or desert climates create dry environmental conditions.  In order to achieve the higher levels of humidity required by regulatory agencies, hospitals and ambulatory surgery centers have to add humidity into the building air, an activity that is expensive and creates its own unique set of challenges.

Dale L. Locklair, FAHRMM, CMRP Vice President of Procurement and Construction McLeod Health Florence, SC

A well-conceived strategic sourcing program starts with an analysis of the total spend or operating expenses of the organization utilizing an “ABC” analysis and category/spend segmentation matrix. This analysis allows for the prioritization of the “sourceable” or “manageable” spend as distinct from other expenses such as taxes, depreciation and interest for which different strategies should be effectively applied.

This paper examines the journey that an organization travels to arrive at an outsource decision and the challenges that it should be alert to post contract. The Literature Review section provides a context for the recommendations offered in the case study illustration. The recommendations deliberately focus on providing proper governance and oversight during the operational phase after the contract has been awarded and is up and running.

Jim Smoker, CMRP, MPA, CS, York, Pennsylvania

The purpose of this paper is to share lessons learned and successes in contract management. Five years ago, Contract Management consisted of signing a few Letters of Commitment through our Group Purchasing Organization and trying to keep track of them in a three ring notebook.

The initial purpose for developing a socially responsible, closed loop supply chain was to enhance our environmentally sustainable practices by purchasing more responsible and locally sourced products.

The paper presents healthcare supply chain tools and strategies for navigating the Cost, Quality, and Outcomes (CQO) Movement, and explores new initiatives designed to advance the supply chain from a transactional program to a strategic contributor to organizational success.

AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following CQO leading practice describes methods used to reduce costs, enhance patient care quality, and drive greater financial outcomes through blood product and service optimization, and was submitted by:

AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infections (CAUTI) leading practice was submitted by: Nexera, Inc., New York, NY

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

How-to guide to managing IV disruptions. Download Tool